1. accedaCRIS
  2. Publicaciones
  3. Actas de congresos
Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/77560
Campo DC Valoridioma
dc.contributor.authorRodriguez Abreu, D.en_US
dc.contributor.authorGarassino, M.C.en_US
dc.contributor.authorEsteban, E.en_US
dc.contributor.authorSperanza, G.en_US
dc.contributor.authorFelip, E.en_US
dc.contributor.authorDomine, M.en_US
dc.contributor.authorHochmair, M.J.en_US
dc.contributor.authorPowell, S.F.en_US
dc.contributor.authorCheng, S.Y.-S.en_US
dc.contributor.authorBischoff, H.en_US
dc.contributor.authorPeled, N.en_US
dc.contributor.authorHui, R.en_US
dc.contributor.authorReck, M.en_US
dc.contributor.authorGaron, E.B.en_US
dc.contributor.authorBoyer, M.en_US
dc.contributor.authorGrossi, F.en_US
dc.contributor.authorJennens, R.en_US
dc.contributor.authorYang, J.en_US
dc.contributor.authorPietanza, M.C.en_US
dc.contributor.authorGadgeel, S.M.en_US
dc.date.accessioned2021-02-05T14:39:18Z-
dc.date.available2021-02-05T14:39:18Z-
dc.date.issued2018en_US
dc.identifier.issn0923-7534en_US
dc.identifier.urihttp://hdl.handle.net/10553/77560-
dc.description.abstractIn KEYNOTE-189 (NCT02578680), pembro plus pem and platinum provided superior OS (HR 0.49, P < .00001) and PFS (HR 0.52, P < .00001) and had manageable safety vs placebo plus pem and platinum as first-line therapy for metastatic nonsquamous NSCLC. In an exploratory analysis, we assessed outcomes by investigator’s choice of carboplatin (carbo) or cisplatin (cis).en_US
dc.languageengen_US
dc.relation.ispartofAnnals of Oncologyen_US
dc.sourceAnnals of Oncology [0923-7534], n. 29 (supl. 8)en_US
dc.subject320101 Oncologíaen_US
dc.title1464P - KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes?en_US
dc.typeinfo:eu-repo/semantics/conferenceObjecten_US
dc.typeConferenceObjecten_US
dc.relation.conferenceEuropean-Society-for-Medical-Oncology Asia Congressen_US
dc.identifier.doi10.1093/annonc/mdy292.086en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Póster de congresosen_US
dc.utils.revisionSíen_US
dc.identifier.ulpgcSíen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr6,047
dc.description.jcr14,196
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.event.eventsstartdate23-11-2018-
crisitem.event.eventsenddate25-11-2018-
Colección:Actas de congresos
Vista resumida

Google ScholarTM

Verifica

Altmetric


Comparte


Exporta metadatos


Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.